Training activity information
Details
Analyse and interpret the results for an imprinting disorder, to include:
- PWS/AS
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What fundamental knowledge about genomic imprinting is required before interpreting results for PWS/AS? Think about the concept of imprinting, the specific genetic mechanisms involved in Prader-Willi Syndrome (PWS) and Angelman Syndrome (AS), and the types of genetic tests used for their diagnosis.
- Consider the nuances of interpreting imprinting disorder results, understanding the different genetic subtypes and their clinical implications, and the importance of considering parental origin of genetic material.
- Will you seek clarification on any aspects of imprinting from your training officer?
- What challenges might you face when analysing and interpreting these results? How might you approach these challenges?
In action
- What testing and analysis strategy are you using?
- What disease mechanisms are you considering?
- How effectively are you able to distinguish between the different genetic mechanisms that can lead to PWS or AS based on the results you are currently examining?
- If you are finding it difficult to differentiate between potential diagnoses based on the current data, what alternative or supplementary analyses might be necessary to clarify the situation? Could you consider different testing methodologies?
- Do you need to consult with a senior colleague regarding the interpretation of a complex or atypical case?
- Are you ensuring that your interpretation carefully considers the parental origin of any identified genetic alterations, as this is crucial for the diagnosis of imprinting disorders?
On action
- Summarise the key data you analysed for potential imprinting disorders.
- What types of assays were involved (e.g., methylation-specific PCR, MLPA, array CGH)?
- What specific results did you observe that were indicative of PWS or AS (or neither)?
- Were there any results suggestive of other imprinting defects or unusual findings?
- What new skills or knowledge did you acquire or enhance regarding the analysis and interpretation of results for imprinting disorders like PWS and AS?
- Did you improve your understanding of the different molecular mechanisms (e.g., deletions, UPD, imprinting defects) that can lead to these conditions?
- Were there any unexpected findings or challenges? What did you learn from these? For instance, did you encounter a case where the molecular results were inconsistent with the clinical presentation?
- Did you need to revisit specific data points or consider alternative explanations based on your initial observations?
- Do you need to deepen your understanding of the critical region on chromosome 15q?
- Would it be beneficial to learn more about the clinical nuances that can differentiate PWS from AS?
- How will you apply what you have learned to future cases involving suspected imprinting disorders?
- Will you be more attentive to specific patterns of results or utilise new resources for interpretation?
- What specific actions will you take to consolidate your knowledge?
Beyond action
- Have you revisited the experiences of analysing and interpreting results for imprinting disorders like PWS/AS? Reflect on how your understanding of the complex molecular mechanisms underlying imprinting disorders has evolved since this training activity.
- Are you now more aware of the nuances in testing strategies and interpretation for these conditions?
- Review your previous reflections on this and related training activities. Have you identified any patterns in your learning or areas where your understanding has significantly deepened over time?
- Has their clinical perspective enhanced your understanding of the challenges in diagnosis and management?
- Consider how your initial exposure to PWS/AS analysis has shaped your approach to interpreting results for other disorders with potential epigenetic mechanisms. Are you now more likely to consider imprinting as a possible explanation for unusual inheritance patterns?
- How have you applied your knowledge of imprinting disorders in subsequent analyses or discussions? Have you been able to contribute more effectively to multidisciplinary team meetings due to this understanding?
- Can you now confidently explain the different genetic and epigenetic mechanisms leading to PWS and AS and the rationale for different testing approaches?
- Identify future learning goals, such as staying informed about advancements in testing technologies for imprinting disorders or developing expertise in interpreting complex methylation patterns.
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Perform targeted analysis for patients referred with paediatric conditions. |
| # 5 |
Outcome
Interpret and report genomic testing relevant to paediatric conditions, including appropriate recommendations for patient management. |